摘要
1988年,AREG被Shoyab等在经12-肉豆蔻酸-13乙酸佛波醇处理后的人乳腺癌MCF-7细胞系上清液中首次发现,由于其既可以促进角质细胞、成纤维细胞的增殖,又可以抑制一些肿瘤细胞系的生长,因此被命名为"双调蛋白"。
Amphiregulin is a member of epidermal growth factor family,and is also one of the ligand of epidermal growth factor receptor,it participates in many physiological and pathological process by combining with EGFR.Researches have proved that AREG participates in asthma and airway inflammatory diseases caused by smoking and PM 2.5,and AREG plays an important role in the process of airway remodeling and inflammation.This paper mainly reviews the expression and function of AREG,and focus on its research status in airway inflammatory disease.
出处
《临床耳鼻咽喉头颈外科杂志》
CAS
北大核心
2018年第1期77-80,共4页
Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金
国家自然科学基金面上项目(No:81770986
No:81371070)
湖北省自然科学基金项目(No:2015CKB756)
关键词
双调蛋白
气道炎性疾病
amphiregulin
epidermal growth factor receptor
airway inflammation
asthma